Monoclonal antibodies as tools to target cell functions

Research output: Contribution to journalArticle

Abstract

Monoclonal antibody (mAb) technology has enabled the creation of mAb of unique specificities and potential large scale production, allowing the study of cell functions. To achieve this goal mAb can be used either as agonists or as inhibitors of a certain biological activity. In the present report we focus on the utilization of mAb technology in basic sciences in particular in the study of cell functions within intracellular compartments. Antibodies can indeed be used to dissect intracellular processes, but the limiting step for this kind of studies is the delivery of mAb to the intracellular compartment without affecting either cell viability or functionality. To overcome this problem several solutions have been explored using either the biological properties of the cells or artificial means. As described hereafter, several successful examples can be scored but all the strategies have drawbacks. Liposome mediated antibody transfer, electroporation and microinjection efficiently deliver mAb intracellularly, but do not target specific subcellular compartments. Recombinant DNA technology instead has provided means to overcome these limitations. This technique allows an intracellular expression of the antibody which can be inducible and limited to particular cell compartments. Furthermore, if high efficiency transduction with a stable vector into stem cells can be achieved, gene transfer mediated "intracellular immunization" might be a feasible treatment strategy in pathology.

Original languageEnglish
Pages (from-to)79-86
Number of pages8
JournalMinerva Biotecnologica
Volume8
Issue number2
Publication statusPublished - 1996

Fingerprint

Monoclonal antibodies
Monoclonal Antibodies
Antibodies
Technology
Artificial Cells
Immunization
Gene transfer
Genetic engineering
Electroporation
Antibody Specificity
Recombinant DNA
Liposomes
Microinjections
Pathology
Bioactivity
Stem cells
Cell Survival
Stem Cells
Cells
Genes

Keywords

  • Cell entry
  • Intracellular immunization
  • Monoclonal antibodies

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Monoclonal antibodies as tools to target cell functions. / Fabbi, Marina; Puccetti, Antonio.

In: Minerva Biotecnologica, Vol. 8, No. 2, 1996, p. 79-86.

Research output: Contribution to journalArticle

@article{59a2c42a4c834fae896881caa4d33420,
title = "Monoclonal antibodies as tools to target cell functions",
abstract = "Monoclonal antibody (mAb) technology has enabled the creation of mAb of unique specificities and potential large scale production, allowing the study of cell functions. To achieve this goal mAb can be used either as agonists or as inhibitors of a certain biological activity. In the present report we focus on the utilization of mAb technology in basic sciences in particular in the study of cell functions within intracellular compartments. Antibodies can indeed be used to dissect intracellular processes, but the limiting step for this kind of studies is the delivery of mAb to the intracellular compartment without affecting either cell viability or functionality. To overcome this problem several solutions have been explored using either the biological properties of the cells or artificial means. As described hereafter, several successful examples can be scored but all the strategies have drawbacks. Liposome mediated antibody transfer, electroporation and microinjection efficiently deliver mAb intracellularly, but do not target specific subcellular compartments. Recombinant DNA technology instead has provided means to overcome these limitations. This technique allows an intracellular expression of the antibody which can be inducible and limited to particular cell compartments. Furthermore, if high efficiency transduction with a stable vector into stem cells can be achieved, gene transfer mediated {"}intracellular immunization{"} might be a feasible treatment strategy in pathology.",
keywords = "Cell entry, Intracellular immunization, Monoclonal antibodies",
author = "Marina Fabbi and Antonio Puccetti",
year = "1996",
language = "English",
volume = "8",
pages = "79--86",
journal = "Minerva Biotecnologica",
issn = "1120-4826",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Monoclonal antibodies as tools to target cell functions

AU - Fabbi, Marina

AU - Puccetti, Antonio

PY - 1996

Y1 - 1996

N2 - Monoclonal antibody (mAb) technology has enabled the creation of mAb of unique specificities and potential large scale production, allowing the study of cell functions. To achieve this goal mAb can be used either as agonists or as inhibitors of a certain biological activity. In the present report we focus on the utilization of mAb technology in basic sciences in particular in the study of cell functions within intracellular compartments. Antibodies can indeed be used to dissect intracellular processes, but the limiting step for this kind of studies is the delivery of mAb to the intracellular compartment without affecting either cell viability or functionality. To overcome this problem several solutions have been explored using either the biological properties of the cells or artificial means. As described hereafter, several successful examples can be scored but all the strategies have drawbacks. Liposome mediated antibody transfer, electroporation and microinjection efficiently deliver mAb intracellularly, but do not target specific subcellular compartments. Recombinant DNA technology instead has provided means to overcome these limitations. This technique allows an intracellular expression of the antibody which can be inducible and limited to particular cell compartments. Furthermore, if high efficiency transduction with a stable vector into stem cells can be achieved, gene transfer mediated "intracellular immunization" might be a feasible treatment strategy in pathology.

AB - Monoclonal antibody (mAb) technology has enabled the creation of mAb of unique specificities and potential large scale production, allowing the study of cell functions. To achieve this goal mAb can be used either as agonists or as inhibitors of a certain biological activity. In the present report we focus on the utilization of mAb technology in basic sciences in particular in the study of cell functions within intracellular compartments. Antibodies can indeed be used to dissect intracellular processes, but the limiting step for this kind of studies is the delivery of mAb to the intracellular compartment without affecting either cell viability or functionality. To overcome this problem several solutions have been explored using either the biological properties of the cells or artificial means. As described hereafter, several successful examples can be scored but all the strategies have drawbacks. Liposome mediated antibody transfer, electroporation and microinjection efficiently deliver mAb intracellularly, but do not target specific subcellular compartments. Recombinant DNA technology instead has provided means to overcome these limitations. This technique allows an intracellular expression of the antibody which can be inducible and limited to particular cell compartments. Furthermore, if high efficiency transduction with a stable vector into stem cells can be achieved, gene transfer mediated "intracellular immunization" might be a feasible treatment strategy in pathology.

KW - Cell entry

KW - Intracellular immunization

KW - Monoclonal antibodies

UR - http://www.scopus.com/inward/record.url?scp=3242861975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242861975&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:3242861975

VL - 8

SP - 79

EP - 86

JO - Minerva Biotecnologica

JF - Minerva Biotecnologica

SN - 1120-4826

IS - 2

ER -